Seer
Seer is a biotechnology company that offers tools and solutions related to the field of proteomics.
Business Model:
Revenue: $14M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Seer Information
Geographic Data
Address: 3800 Bridge Parkway
City: Redwood City
State: CA
Zip: 94065
Country: US
Financial Info
Stage:
Raised Last:
$55M
Raised Total:$170M
Social
Twitter
Linkedin
Crunchbase
Metrics
1,552,698Website Global Rank
16,186Website Monthly Traffic
Twitter Followers
Description
Seer is a developer of a life sciences and health data platform intended to facilitate early, pre-symptomatic detection of chronic life-threatening diseases. The company&s;s platform captures and translates molecular insights from the proteome with improved accuracy and speed, enabling healthcare professionals to detect cancer and neurological diseases, drive earlier treatment and improve patient outcomes.
Contact Phone:
+14083071702
Contact Email:
Seer went public on 12/3/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
12/3/2020
IPO Valuation:
$1B
Ticker Symbol:
SEER
IPO Price:
$19/share
Amount Raised:
$175M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
